Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
13.44
+0.11 (0.83%)
May 23, 2025, 2:45 PM CST
14.09%
Market Cap 11.01B
Revenue (ttm) 4.05B
Net Income (ttm) 704.05M
Shares Out 825.93M
EPS (ttm) 0.83
PE Ratio 16.05
Forward PE 13.46
Dividend 0.35 (2.63%)
Ex-Dividend Date May 24, 2024
Volume 11,077,700
Average Volume 9,796,623
Open 13.23
Previous Close 13.33
Day's Range 13.23 - 13.65
52-Week Range 9.88 - 14.78
Beta 0.10
RSI 52.12
Earnings Date Aug 15, 2025

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Sector Healthcare
Founded 1990
Employees 3,869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.

Financial Statements

News

There is no news available yet.